Table 1.
Characteristics of patients.
| Characteristics | Persistent (n = 91); n (%) | Non-persistent (n = 47); n (%) | p |
|---|---|---|---|
| Sex ratio | |||
| Men | 59 (63) | 33 (67) | 0.092 |
| Age (mean, SD) | 67 (17) | 49 (19) | 0.004 |
| Immunodepression background | |||
| 0: None | 0.067 | ||
| 1: Diabetes mellitus | 35 (46) | 28 (48) | |
| 2: Malign hemopathies | 22 (29) | 4 (7) | |
| 3: Solid organ graft | 4 (5) | 0 (0) | |
| 4: Active organ solid malignancy with CT or IT | 5 (6) | 2 (3) | |
| 5: auto-immune disease treated by IT or IST | 5 (6) | 3 (5) | |
| Missing data | 3 (4) | 3 (5) | |
| 2 (2) | 20 (30) | ||
| COVID 19 treatments | 0.151 | ||
| AZ alone | 5 (5) | 4 (6) | |
| AZ + DXM | 5 (5) | 1 (2) | |
| AZ + IVE | 1 (1) | 0 (0) | |
| HCQ + AZ | 18 (9) | 18 (30) | |
| HCQ + AZ + DXM | 7 (8) | 0 (0) | |
| DXM alone | 16 (17) | 7 (12) | |
| Anti C5a | 1 (1) | 0 (0) | |
| Missing data | 7 (8) | 8 (13) | |
| No specific treatment | 28 (30) | 22 (36) | |
| Severity stage of disease | |||
| 1: mild | 21 (22) | 21 (35) | 0.092 |
| 2: moderate | 19 (21) | 11 (18) | 0.741 |
| 3: severe | 21 (22) | 3 (5) | 0.022 |
| 4: death | 9 (10) | 1 (2) | 0.065 |
| Missing data | 27 (29) | 22 (36) | |
| ICU admission | |||
| Yes | 25 (26) | 4 (7) | 0.018 |
| No | 47 (50) | 34 (56) | 0.714 |
| Missing data | 21 (23) | 20 (30) | |
IT: immunotherapy; IST: immunosuppressive therapy; AZ: azithromycin; DXM: dexamethasone; HCQ: hydroxychloroquine; IVE: ivermectin; ICU: intensive care unit.
Significant values are in bold and italics.